CVST: To DOAC or Not

Tuesday, February 25, 2025

11:35am – 11:50am Eastern Time

Location: Valencia Ballroom/415A

Khalid Alsherbini, MD (he/him/his)

University of Arizona College of Medicine-Phoenix

Disclosure(s): Ceribell Inc: Consultant (Ongoing); UCB: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated)

Disclosure(s):

Khalid Alsherbini, MD: Ceribell Inc: Consultant (Ongoing); UCB: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated)

This session will address the treatment of cerebral venous sinus thrombosis (CVST) and will cover DOACs vs warfarin.